Why Procter & Gamble Could Head Even Higher

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Shares of Procter & Gamble (NYSE: PG  ) hit a 52-week high on Friday. Let's take a look at how it got there and see whether clear skies are still in the forecast.

How it got here
If I told you that Procter & Gamble had lowered its outlook twice this year already, you'd probably be in bewilderment, seeing that the stock is currently at a 52-week high -- but it's true! P&G has suffered through a myriad of issues this past year, including weak consumer-spending habits that have caused consumers to trade down to lower-margin products, tough competition, and a stronger dollar that hurts its overseas sales.

In spite of these issues, P&G's resilience has shown through, and it's focused on multiple growth and market-share growth initiatives. To begin with, P&G is watching its costs like a hawk. It announced plans earlier this year to cut 5,700 jobs before the end of its fiscal 2013 but noted that these cuts would be countered with hiring in high-growth emerging-market areas and China. It also made a decent profit in the fourth quarter from the sale of the Pringles snack brand to Kellogg (NYSE: K  ) .

P&G also stands prepared to introduce new products and push its higher-priced household and beauty products. The company feels confident that we're on the precipice of a major shift in consumer trends that will have more people choosing to trade up to brand-name products.

Finally, P&G has price inelasticity on its side. Even though it was forced to scale back some of its price increases earlier this year, many of its products are near-necessity items that offer relative price and cash-flow stability.

What's keeping P&G from moving higher is the following army of hyphens and ampersands: Kimberly-Clark (NYSE: KMB  ) , Johnson & Johnson (NYSE: JNJ  ) , Church & Dwight (NYSE: CHD  ) , and Colgate-Palmolive.

How it stacks up
Let's see how Procter & Gamble stacks up next to its peers.

PG Chart

PG data by YCharts

That would indeed P&G bringing up the rear, with the much smaller Church & Dwight leading the pack.


Price/ Book

Price/ Cash Flow

Forward P/E

Dividend Yield

Procter & Gamble 3 15.2 15.5 3.2%
Kimberly-Clark 6 12.6 14.1 3.5%
Johnson & Johnson 3.1 12.1 12.2 3.5%
Church & Dwight 3.9 17.6 19.8 1.6%
Colgate-Palmolive 3 17.4 17.6 2.3%

Source: Morningstar.

One thing about conglomerates is that their financials are often painfully similar, and so it's tough to distinguish strengths and weaknesses. What we can say is that each company here faces a unique set of struggles.

P&G is cheap relative to book value in this group, but it's had trouble maintaining its market share and pricing against other detergent makers. Kimberly-Clark offers a premium dividend at 3.5% but has not had much success in expanding internationally, as I've discussed previously. Johnson & Johnson could be the best value of this group, as it recently completed a $19.7 billion purchase of medical-device maker Synthes. Church & Dwight appears to be the priciest of the group based on these metrics and is also the most recent company here to lower its earnings forecast because of weak consumer spending. Finally, Colgate-Palmolive has felt the pangs of increased input cost inflation.

Each company offers its own set of well-known brand names and steady cash flow, but each has concerns to address about where future growth will come from.

What's next
Now for the $64,000 question: What's next for Procter & Gamble? That question depends on whether it can maintain pricing power, if it can maintain its U.S. market share while promoting growth in emerging markets, and if it can create shareholder value through share buybacks and dividend increases.

Our very own CAPS community gives the company a highly coveted five-star rating, with 96.9% of members expecting it to outperform. I, too, count myself among the vast majority having made a CAPScall on P&G, and mine is currently down about four points.

It's true that P&G has ample challenges that lie ahead, but it's taking the appropriate steps to regain its lost market share and reinvigorate growth. As long as P&G continues its push into emerging markets, uses its pricing power to fend off rising inflationary costs, and rewards shareholders (i.e., the recently initiated $4 billion share buyback), I see little reason this won't head higher over the long run.

While P&G has been a Dow Jones Industrial Average standout stock, the Dow index is a minefield of fantastic dividends. In our latest special report from Stock Advisor, you can find out, for free, which two other companies join P&G as the cream of the crop in Dow dividends. Get this report and claim your investing edge.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of Procter & Gamble, Kimberly-Clark, and Johnson & Johnson, as well as creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy that's hyphen and ampersand friendly.

Read/Post Comments (1) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On September 11, 2012, at 1:25 PM, whyaduck1128 wrote:

    I love headlines with "could", "can", "might", and "may in them. Way to take a stand. Whichever way things break, the headline writer isn't wrong.

    I had to laugh when I saw the graphic. The first thing I noticed was that it was for five stocks, and I said to myself, "I'm sure I own the bottom two or three". Sure enough, I'm long PG, JNJ, and KMB. I'm not complaining, though, as (a) I haven't been in the market for the entire period of the graphic, and (b) I'm up over the period I've been in.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2012248, ~/Articles/ArticleHandler.aspx, 10/28/2016 10:49:18 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,223.82 54.14 0.30%
S&P 500 2,138.85 5.81 0.27%
NASD 5,226.51 10.53 0.20%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 10:33 AM
PG $86.90 Up +0.32 +0.37%
Procter and Gamble CAPS Rating: ****
CHD $47.98 Up +0.25 +0.52%
Church and Dwight CAPS Rating: ***
JNJ $115.48 Down -0.22 -0.19%
Johnson and Johnso… CAPS Rating: *****
K $74.63 Up +0.47 +0.63%
Kellogg's CAPS Rating: ****
KMB $114.78 Up +0.96 +0.84%
Kimberly-Clark CAPS Rating: ****